We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Phase I Study to Evaluate the Immunologic Response and Virologic Impact of AGS-004

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT02042248
First Posted: January 22, 2014
Last Update Posted: May 4, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Argos Therapeutics
National Institute of Allergy and Infectious Diseases (NIAID)
Information provided by (Responsible Party):
Cynthia L Gay, MD, University of North Carolina, Chapel Hill
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2016
  Primary Completion Date: May 2016 (Final data collection date for primary outcome measure)